
PureTech Health gets US$11.4m to advance LYT-300
PureTech Health plc has been awarded up to $11.4 million from the US government to advance LYT-300 (oral allopregnanolone) for the treatment of...

Gleamer raises €27m in Series B funding round
Gleamer SAS’ financing round was led by Supernova Invest, co-led by Heal Capital and backed by Gleamer’s long-term partners XAnge, Elaia, Bpifrance...

Novo Nordisk takes over Inversago Pharma Inc.
As competiion for Novo Nordisk A/S’ subcutanously administered blockbuster GLP1-receptor blocker semaglutide is growing, particularly as an obesity...

Promising viral gene therapy for genetic kidney disease
UK resesearchers have engineered an adeno-associated virus vector to treat the heriditary steroid-resistant nephrotic syndrome in children, which is...

Bavarian Nordic A/S bags US$120m for smallpox vaccine
Under a deal with the US agency BARDA, Bavarian Nordic A/S (Copenhagen) will cash in US$96m in 2023 ffor the manufacturing of a n new buk product of...

Dutch go first: pre-approval tastings of cultivated meat & seafood in the Netherlands
Mosa Meat and Meatable welcome the agreement with the Dutch government to conduct pre-approval tastings of cultured meat and seafood in the...